Benjamin Winograd

Benjamin Winograd

63 year
Health Technology
Consumer Services
Commercial Services

Profile

Benjamin Winograd worked as an Executive Director-Clinical Oncology at Bristol Myers Squibb Co. from 1990 to 1999.
He then worked as Vice President-Global Medical Affairs & Oncology at Schering-Plough Biopharma from 2004 to 2007.
From 2007 to 2020, he worked at Celgene Corp.
as Head-Clinical R&D Therapeutic Area.
Currently, he is the Chief Medical Officer at LAVA Therapeutics NV, a position he started in 2020 and will hold until 2023.
Dr. Winograd received his graduate and doctorate degrees from Technische Universität München.

Former positions of Benjamin Winograd

CompaniesPositionEnd
LAVA THERAPEUTICS N.V. Chief Tech/Sci/R&D Officer 2023-02-05
CELGENE Corporate Officer/Principal 2019-12-31
Corporate Officer/Principal 2006-12-31
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 1998-12-31
See the detail of Benjamin Winograd's experience

Training of Benjamin Winograd

Technische Universität München Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Benjamin Winograd's experience

Connections

100 +

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

LAVA THERAPEUTICS N.V.

Health Technology

Private companies2

Health Technology

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Benjamin Winograd